<DOC>
	<DOCNO>NCT02385422</DOCNO>
	<brief_summary>To compare efficacy safety Carvedilol Propranolol patient cirrhosis-related esophagogastric varix multiple endoscopic treatment secondary prophylaxis .</brief_summary>
	<brief_title>The Effect Carvedilol Vs Propranolol Cirrhotic Patients With Variceal Bleeding</brief_title>
	<detailed_description>The study randomize control trial . Patients randomly enter two treatment group : 1 ) Carvedilol group 2 ) Propranolol group . Treatment allocation block randomization , equal number Carvedilol Propranolol . The result conceal opaque envelope . The dose non-selective β-blocker ( NSBB ) titrate accord systolic arterial blood pressure ( ABPsys ) heart rate ( HR ) . Doses increase every 2-3 day ABPsys le 90 mm Hg HR le 55 bpm . Carvedilol start dose 6.25mg/d , titrate maximum dose 25mg/d . Patients receive propranolol start dose 30 mg/day dose increase maximum dose 160 mg/day . Patients follow telephone call every 2 month . After take 2 drug 6 month , patient come clinic visit , receive laboratory test endoscopic examination , event primary secondary outcome analyze .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>age 1870 year old ; cirrhotic patient refer Zhongshan Hospital esophagogastric varix confirm endoscopy ; history variceal bleeding ; least 3 time endoscopic treatment ; 1 ) mild esophageal varix ; 2 ) gastric varix diameter less 5mm ; 3 ) variceal eradication time recruit . Patients exclude episode variceal bleed last endoscopic treatment ; diagnosis hepatic cellular carcinoma ; severe systemic disease ; refractory ascites ; contraindication Carvedilol Propranolol , : asthma , chronic obstructive pulmonary disease , allergic rhinitis , New York Heart Association IV chronic heart failure , atrioventricular blockade , severe bradycardia ( HR &lt; 50bpm ) , sick sinus syndrome , cardiogenic shock , severe hypotension ( ABPsys &lt; 85mmHg ) ; previous continue use βblockers ; Child Pugh Class C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>secondary prophylaxis</keyword>
	<keyword>Propranolol</keyword>
	<keyword>Carvedilol</keyword>
	<keyword>comparative effectiveness research</keyword>
</DOC>